Sign Up Today and Learn More About Enable Medicine Stock
Invest in or calculate the value of your shares in Enable Medicine or other pre-IPO companies through EquityZen's platform.
Enable Medicine Stock
Enable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery.
About Enable Medicine Stock
Founded
2019
Headquarters
Menlo Park, CA, US
Notable Investor
Anthos Capital
Industries
Enable Medicine is a biotechnology company that accelerates insight discovery by generating, managing, and analyzing spatial biology data on the enable cloud platform. Run experiments, decrease costs, and accelerate time to insight. The Enable Cloud Platform provides a collaborative ecosystem and tools for generating, visualizing, and analyzing many biological image formats. Enable Medicine was established in 2019 by Aaron Mayer and Sunil Bodapati in Menlo Park, California.
Enable Medicine Press Mentions
Stay in the know about the latest news on Enable Medicine
Enable Medicine. (2/13/24). "Press Release: Enable Medicine Appoints Kamni Vijay as Chief Executive Officer". Menlo Park, CA.
mass-spec-capital • Apr, 15 2024
Enable Medicine Appoints Kamni Vijay as Chief Executive Officer
businesswire • Apr, 8 2024
Enable Medicine Announces Publication in Science Immunology Showing Spatial Transcriptomics Reveal Distinct ...
businesswire • Apr, 8 2024
Enable Medicine Appoints Kamni Vijay as Chief Executive Officer
biospace • Feb, 13 2024
Startups Are Using AI to Predict Responses to Cancer Drugs
wsj • Jan, 19 2024
Investors in Enable Medicine
Discover investors in Enable Medicine stock and explore their portfolio companies
Enable Medicine Management
Leadership team at Enable Medicine
Co-Founder and CEO
Sunil Bodapati
Co-founder, CSO
Aaron Mayer
Join now and verify your accreditation status to gain access to:
- Enable Medicine current valuation
- Enable Medicine stock price
- Available deals in Enable Medicine and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Enable Medicine stock?
Accredited investors can buy pre-IPO stock in companies like Enable Medicine through EquityZen funds. These investments are made available by existing Enable Medicine shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Enable Medicine stock?
Shareholders can sell their Enable Medicine stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
